135 results
SC TO-T/A
EX-99
ZYNE
Zynerba Pharmaceuticals, Inc.
11 Oct 23
Third party tender offer statement (amended)
8:31am
disabilities and behavioral symptoms, such as social avoidance and irritability. There are approximately 80,000 people in the U.S. and approximately … issues, as well as debilitating neuropsychiatric and behavioral symptoms, including anxiety, social withdrawal, ADHD, cognitive impairment and autism
SC TO-T
EX-99
HRMY
Harmony Biosciences Holdings Inc
28 Aug 23
Third party tender offer statement
8:23am
Print)
Address
(Include Zip Code)
(Taxpayer Identification or Social Security Number)
(See Specific Instructions to Internal Revenue Service
Form W-9 … :
(Include Zip Code)
Daytime Area Code and Telephone Number:
Taxpayer Identification or Social Security No:
GUARANTEE OF SIGNATURE(S)
(For use
SC TO-T
EX-99
HRMY
Harmony Biosciences Holdings Inc
28 Aug 23
Third party tender offer statement
8:23am
Number or Social Security Number
Unless otherwise indicated, it will be assumed that all Shares held by us for your account are to be tendered.
SC TO-C
EX-99.2
ZYNE
Zynerba Pharmaceuticals, Inc.
14 Aug 23
Information about tender offer
5:29pm
, such as social avoidance and irritability. There are approximately 80,000 people in the U.S. and approximately 121,000 people in the European Union … neuropsychiatric and behavioral symptoms, including anxiety, social withdrawal, ADHD, cognitive impairment and autism spectrum disorder. It is estimated
SC TO-C
EX-2.1
ZYNE
Zynerba Pharmaceuticals, Inc.
14 Aug 23
Information about tender offer
5:29pm
in place,” “stay at home,” workforce reduction, social distancing, shut down, closure, sequester, safety or similar Law, directive, protocols … and Accountability Act of 1996); Medicare and Medicaid coverage and reimbursement provisions (Titles XVIII and XIX of the Social Security Act
SC TO-C
EX-99.2
nectgpzbwto1xb
14 Aug 23
Information about tender offer
5:26pm
SC TO-C
EX-99.1
t92q5e k0jbcitv2
14 Aug 23
Information about tender offer
5:26pm
8-K
EX-99.2
sd8vw
14 Aug 23
Tender and Support Agreement
7:42am
8-K
EX-2.1
5wrf72jlg8s
14 Aug 23
Tender and Support Agreement
7:42am
DEFA14A
x2b0lp2
15 May 23
Additional proxy soliciting materials
7:08am
8-K
EX-99.2
r34m1s3y zqkmeg6h
15 May 23
Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results
7:05am
8-K
EX-99.1
sq05uwxk 6p2zr
15 May 23
Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results
7:05am